Quantitatively and qualitatively greater migration of T cells, including those recognizing V937 and tumor-associated antigens, furthered by increased expression of PD-L1 within the tumor microenvironment after treatment initiation, may also have contributed to efficacy. Here, CD274 is linked to neoplasm.